UK pharma major GSK today revealed that it has licensed its Shigella vaccine candidate, altSonflex1-2-3, to India’s Bharat ...

Belgium’s largest drugmaker UCB has announced plans for a significant investment in a new, state-of-the-art biologics ...

The American medicines regulator has approved Zusduri (mitomycin), a hydrogel-based treatment developed by US biotech UroGen ...

The Russian pharmaceutical market is showing positive dynamics these days, despite the ever-tightening sanctions regime and ...

Novartis has unveiled further data for Fabhalta (iptacopan), reinforcing its position in the paroxysmal nocturnal ...

Russian drugmaker Axelpharm has managed to lift the ban on the launch of osimertinib - a drug, which is used in the treatment ...

COVID success story BioNTech (Nasdaq: BNTX) is to buy fellow German mRNA company CureVac (Nasdaq: CVAC). Shares in the latter ...

South Korea’s LigaChem Biosciences has signed two antibody licensing agreements with US biotech NovaRock Biotherapeutics, reports Korea Biomedical Review.

Research services company IQVIA has unveiled new AI agents built using NVIDIA technology that are designed to enhance ...

USA-based biotech Vaxart has reported positive top-line results from a Phase I trial comparing its second-generation oral ...

US biotech Novavax (Nasdaq: NVAX) has reported that its experimental combination COVID-19 and influenza vaccine generated ...

Kite, unit today presented the latest results that demonstrate a 79% overall response rate (ORR) and 74% overall survival (OS ...